DexCom Inc.

70.75
3.89 (5.82%)
At close: Apr 24, 2025, 3:59 PM

DexCom Statistics

Share Statistics

DexCom has 392.11M shares outstanding. The number of shares has increased by -1.74% in one year.

Shares Outstanding 392.11M
Shares Change (YoY) -1.74%
Shares Change (QoQ) 0.05%
Owned by Institutions (%) 90.3%
Shares Floating 386.62M
Failed to Deliver (FTD) Shares 106
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 11.01M, so 2.81% of the outstanding shares have been sold short.

Short Interest 11.01M
Short % of Shares Out 2.81%
Short % of Float 3.6%
Short Ratio (days to cover) 2.74

Valuation Ratios

The PE ratio is 54.61 and the forward PE ratio is 26.77. DexCom's PEG ratio is 39.32.

PE Ratio 54.61
Forward PE 26.77
PS Ratio 7.8
Forward PS 3.3
PB Ratio 14.97
P/FCF Ratio 49.89
PEG Ratio 39.32
Financial Ratio History

Enterprise Valuation

DexCom has an Enterprise Value (EV) of 33.39B.

EV / Sales 8.28
EV / EBITDA 39.72
EV / EBIT 33.74
EV / FCF 52.94

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 1.2.

Current Ratio 1.47
Quick Ratio 1.28
Debt / Equity 1.2
Debt / EBITDA 3.01
Debt / FCF 4.01
Interest Coverage 31.58

Financial Efficiency

Return on Equity is 27.4% and Return on Invested Capital is 10.2%.

Return on Equity 27.4%
Return on Assets 8.89%
Return on Invested Capital 10.2%
Revenue Per Employee $395.39K
Profits Per Employee $56.49K
Employee Count 10,200
Asset Turnover 0.62
Inventory Turnover 2.89

Taxes

Income Tax 132.8M
Effective Tax Rate 18.73%

Stock Price Statistics

The stock price has increased by -51.32% in the last 52 weeks. The beta is 1.5, so DexCom's price volatility has been higher than the market average.

Beta 1.5
52-Week Price Change -51.32%
50-Day Moving Average 74.99
200-Day Moving Average 77.47
Relative Strength Index (RSI) 44.48
Average Volume (20 Days) 4.23M

Income Statement

In the last 12 months, DexCom had revenue of 4.03B and earned 576.2M in profits. Earnings per share was 1.46.

Revenue 4.03B
Gross Profit 2.47B
Operating Income 600M
Net Income 576.2M
EBITDA 840.7M
EBIT 627.5M
Earnings Per Share (EPS) 1.46
Full Income Statement

Balance Sheet

The company has 606.1M in cash and 2.53B in debt, giving a net cash position of -1.92B.

Cash & Cash Equivalents 606.1M
Total Debt 2.53B
Net Cash -1.92B
Retained Earnings 1.6B
Total Assets 6.48B
Working Capital 1.37B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 989.5M and capital expenditures -358.8M, giving a free cash flow of 630.7M.

Operating Cash Flow 989.5M
Capital Expenditures -358.8M
Free Cash Flow 630.7M
FCF Per Share 1.56
Full Cash Flow Statement

Margins

Gross margin is 61.14%, with operating and profit margins of 14.88% and 14.29%.

Gross Margin 61.14%
Operating Margin 14.88%
Pretax Margin 17.58%
Profit Margin 14.29%
EBITDA Margin 20.85%
EBIT Margin 14.88%
FCF Margin 15.64%

Dividends & Yields

DXCM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield 1.83%
FCF Yield 2%
Dividend Details

Analyst Forecast

The average price target for DXCM is $99.5, which is 48.2% higher than the current price. The consensus rating is "Buy".

Price Target $99.5
Price Target Difference 48.2%
Analyst Consensus Buy
Analyst Count 18
Stock Forecasts

Stock Splits

The last stock split was on Jun 13, 2022. It was a forward split with a ratio of 4:1.

Last Split Date Jun 13, 2022
Split Type forward
Split Ratio 4:1

Scores

Altman Z-Score 5.14
Piotroski F-Score 6